Milann Fertility & Birthing Hospital brought together more than 350 fertility specialists, clinicians, embryologists and academicians at the Comprehensive Fertility Conclave 2026, spotlighting the need for standardisation, transparency and measurable outcomes in assisted reproductive technology as infertility care demand continues to rise across India.
Held under the theme “Genesis of Life: Innovation in Fertility Medicine,” the conclave focused on aligning fast-evolving fertility science with everyday clinical practice, particularly at a time when outcome variability across centres remains a concern for patients and doctors alike.
The event was led by Dr Meghana Nyapathi, Organising Chairperson, along with Dr Praveen Joshi and Dr Sunitha Mahesh as Organising Joint Secretaries. It also featured international faculty participation, including Dr Yannis Panagiotidis.
Ms Anjali Ajaikumar, Director, Milann, Fertility and Birthing Hospital, said infertility is now a broader public health issue shaped by lifestyle changes, delayed parenthood, metabolic disorders such as PCOS and rising stress levels. “At Milann, we strongly believe that standardisation and transparency are the cornerstones of patient trust. Through CFC 2026, our goal is not just knowledge exchange, but collective accountability,” she said.
A central theme at the conclave was the push to reduce variability in IVF outcomes through protocol consistency, laboratory discipline and data accountability. Sessions highlighted the use of IVF laboratory dashboards and KPI-based monitoring as tools to improve transparency and track performance more systematically across fertility centres.
Scientific discussions covered a wide range of clinical issues, including Advanced Fertility Clinic models, PCOS- and obesity-linked infertility, ovarian ageing and advanced male infertility diagnostics, including DFI and genetic evaluation. The agenda also explored the evidence-based use of PGTA, ERA and immune therapies, reflecting the field’s shift toward more data-driven and individualised treatment planning.
A recurring concern across the sessions was the need to bridge andrology and ART, with experts stressing deeper male-factor workups as part of routine fertility care. The programme also showcased sessions on building IVF lab KPI dashboards, reinforcing the move toward outcome transparency in fertility practice.
Ahead of the main conclave, Milann conducted hands-on workshops and simulation modules covering Micro-TESE, rapid vitrification and procedures such as OPU, IUI and embryo transfer. These training sessions were designed to strengthen surgical ergonomics and laboratory precision, while giving clinicians practical exposure to complex ART workflows.
Milann said participating centres will work over the coming year to strengthen structured data tracking, integrate male fertility assessment more routinely into practice and expand skill-based ART training programmes. The hospital said the broader aim is to improve consistency in fertility care delivery as more couples seek assisted reproduction in India.
The conclave comes at a time when fertility medicine is increasingly being shaped by both clinical innovation and patient expectations for clearer outcomes. By putting standardisation and accountability at the centre of the conversation, CFC 2026 reflected a growing industry consensus that access alone is not enough, and that measurable, transparent care will be critical to the next phase of ART in India.
